IRIDEX CORP — Director's Dealing 2012

May 24, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2012-05-21

Reporting Person: NAUMANN-ETIENNE RUEDIGER (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-21	Common Stock	S	300	$4.15	Disposed	64019	Indirect

Footnotes

F1: The Reporting Person is a general partner of Intertec Healthcare Partners LP ("Intertec") and may be deemed to share voting and dispositive power of the shares held by Intertec. The Reporting Person disclaims beneficial ownership of the shares held by Intertec, except to the extent of his proportionate partnership interest therein.